Current trials
Card Grid - Our clinical trials
A study for ovarian cancer patients that aims to show whether there is an association between participation in exercise and greater adherence to chemotherapy.
A study to evaluate the feasibility, safety and potential benefits of an individually tailored, exercise intervention during chemotherapy for recurrent ovarian, primary peritoneal or fallopian tube cancer.
The EN.10 trial is a Phase II study that focuses on finding the best follow-up treatment after surgery for early-stage endometrial cancer. Specifically, the trial looks at cancers with certain genetic traits. The main goal is to see how often cancer returns in the pelvic area over a three-year period when a reduced or customised post-surgery treatment is used.
A Randomised Controlled Trial (RCT) comparing Sentinel Lymph Node Dissection (SLND), a commonly performed procedure for the surgical staging of early stage endometrial cancer, to No Node Dissection.
Targets obese, young or co-morbid patients with early endometrial cancer and aims to treat these women less invasively through the use of the Mirena IUD which treats the cancer from inside the uterus.
Researchers will use blood and tissue samples collected as part of the feMMe trial, to identify whether a endometrial cancer patient will or will not benefit from Levonorgestrel delivered through an intrauterine device (LNG-IUD), in place of a hysterectomy.
Getting the MOST out of follow-up: a randomised controlled trial to compare three-monthly nurse-led telephone follow-up, including monitoring serum CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic-based follow-up, following completion of first-line chemotherapy in patients with epithelial ovarian cancer.
A randomised feasibility trial that compares groin ultrasound surveillance with groin node surgery in Queensland women with vulvar cancer, aiming to reduce the extent of surgery and to improve the patient outcomes and determine whether it's necessary to remove groin lymph nodes in cases of early-stage vulvar cancer.
The aim of this controlled feasibility study is to assess whether non-invasive groin ultrasound is a feasible and accurate method of predicting nodal involvement in vulvar cancer patients. If so, the ability to predict the absence of nodal involvement may spare future vulvar cancer patients unnecessary LND procedures to reduce complications, improve recovery time, and facilitate their return to normal daily activities.
This research project aims to evaluate the effectiveness and safety of Dostarlimab, a new treatment for patients with early-stage endometrial cancer for those who either cannot undergo or do not want surgery, or who wish to preserve their fertility.
A study aimed to determine whether removing the fallopian tubes while delaying the removal of the ovaries is as effective in preventing ovarian cancer as removing both the tubes and ovaries at the same time. This study focuses on women at high risk of ovarian cancer due and whether this alternative approach is equivalent to the standard method in preventing ovarian cancer for women without the associated symptoms and risks.